Zoledro-Denk

Solution for Infusion

Short description

Prevention and treatment of bone-related complications due to cancer. Treatment of osteoporosis (decreased bone density).

Dosage form

Solution for Infusion

Active ingredient and dose

Zoledronic acid 4 mg/5 ml
Please note that the availability of our products may vary depending on the region. We recommend that you check the availability of our products in your country before purchasing.

Further products

Do you have further questions about our products?

Denk Pharma

You are now leaving the English version of our website. This link will take you to the newly selected language version. The content of these pages may differ accordingly.

Note on the product portfolio

Please also note that some of the products shown are only available in selected regions. Please enquire about product availability in your region.